Terminal Sterilization Services Market Size, Share & Trends Report

Terminal Sterilization Services Market Size, Share & Trends Analysis Report By Product (Ethylene Oxide, Irradiation, Moist Heat Terminal Sterilization), By End-use (Hospitals & Clinics, Pharma), By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Apr, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-4-68039-416-6
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 110

Report Overview

The global terminal sterilization services market size was valued at USD 8.8 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 10.3% from 2021 to 2028. High prevalence of chronic diseases, rising incidence of Healthcare Acquired Infections (HAIs), and impact of COVID-19 outbreak are among the key factors driving the market. Sterilization products such as heat sterilizers, ethylene oxide, and others are experiencing increasing demand at present from across the globe to handle a surge of COVID-19. Owing to high demand for proper sanitization of equipment and surrounding has tremendously boosted the use of sterilization equipment and services in hospitals, clinics, diagnostic laboratories, pharmaceutical manufacturing units, and the biopharmaceutical industry.

U.S. terminal sterilization service market size, by product, 2016 - 2028 (USD Billion)

Continuous rise in the COVID-19 cases globally has spurred the demand for terminal sterilization services across the world. According to the data of Worldometer, there were more than 142,096,751 million cases of COVID-19 as reported on April 19, 2021. There are over 3,034,989 million deaths reported worldwide. This exponential rise has propelled the companies to develop effective sterilizers which are majorly utilized by the laboratories and the hospitals for the cleaning of medical devices and equipment to avoid cross-contamination, thus, driving the demand for terminal sterilization services. Moreover, the government is providing easy regulatory approval and permission to new products utilized in the COVID-19 pandemic. For instance, in April 2020, the U.S. FDA and Dutch National Institute for Public Health and the Environment granted Advanced Sterilization Products (ASP) an Emergency Use Authorization to decontaminate single-use N95 respirators by STERRAD system for healthcare professionals. This step could add a daily capacity of about 4 million masks nationwide.

Moreover, rise in healthcare-acquired infections due to contaminated instruments and lack of preventive measures is another major factor that is projected to fuel the demand for terminal sterilization services across healthcare facilities. For instance, as per the CDC in 2018, it was estimated that HAIs account for 1.7 million infections and 99,000 associated deaths every year in American hospitals. Similarly, according to the European Centre for Disease Prevention and Control (ECDC) in 2018, the prevalence of HAIs was around 7.1% in European countries and it was also estimated that around 8.9 million HAIs occur each year in European hospitals and other medical facilities. Such cases are expected to increase the demand for terminal sterilization of hospital equipment and surroundings. Terminal sterilization helps in reducing the spread of infections, and diseases. This is expected to help cater to the growing demand for terminal sterilization services during the forecast period.

Furthermore, rapid technological advancements have led to the launch of innovative product launch, which is anticipated to accelerate the growth of the market for terminal sterilization services during the forecast period. Under the terminal sterilization services, low temperature hydrogen peroxide sterilization has emerged as one of the most promising alternates for conventional sterilization techniques. As this technique is free from highly hazardous chemicals and cycle completion time is also shorter. Owing to such factors the espousal of plasma sterilization techniques is expected to witness substantial growth in the coming years. For instance, in April 2020, the U.S. FDA approved the use of Steris V-PRO 1 Plus, maX2, and maX low-temperature sterilization systems for decontamination of N95 respirators and similar masks each day in hospitals used for treating COVID-19 patients. Apart from H2O2 sterilization, pulsed light sterilization has also gained significant popularity in the market over the past few years. As this process is also chemical-free and involves the use of high-intensity pulsed light for short durations, thereby, safe for disinfection of foods. Thus, the aforementioned factors are expected to boost market growth over the forecast period.

The U.S. dominated the market for terminal sterilization services and account for the largest revenue share in 2020 owing to the high prevalence of hospital-acquired infections and increasing number of surgeries. For instance, as per the Healthcare Information and Management Systems Society, each day, 1 out of 25 patients in the U.S. are affected by hospital-acquired infection. An increase in the number of hospitals and the prevalence of infectious diseases such as tuberculosis, dengue, malaria, and typhoid including the current pandemic of COVID-19 is expected to drive the market in the U.S. Moreover, a well-defined regulatory framework and availability of experienced professionals to operate sterilization equipment are some other factors fueling the market growth in the country. This is expected to positively impact the market during the forecast period.

Furthermore, increase in the incidence of chronic diseases, such as diabetes, cancer, and other autoimmune diseases, is anticipated to boost the demand for terminal sterilization services in healthcare facilities. Increased adoption of an unhealthy and sedentary lifestyle, and antimicrobial resistance, are some of the major factors contributing to the growing prevalence of chronic diseases. According to the U.S. National Center for Health Statistics 2018, an estimated 157 million people in America are living with chronic disease, with 81 million having multiple conditions. Thus, rising prevalence of chronic conditions has significantly increased the hospital admission rate. The healthcare facilities constantly require cleaning, disinfection, and sterilization process in order to reduce hospital-acquired infections. Such factors are expected to drive the demand for terminal sterilization services during the forecast period.

Product Insights

The ethylene oxide segment dominated the market for terminal sterilization services and accounted for the largest revenue share of 34.9% in 2020. Ethylene oxide has been widely utilized as a low-temperature sterilization technique from the early 20th century and has been found to be compatible with most of the medical devices and materials. This sterilization technique is used as an alternative to steam/dry heat for sterilizing moisture-intolerant or heat-sensitive surgical equipment and supplies in healthcare facilities. Thus, items/devices that cannot endure extreme temperature and humidity can be treated by this technique, thereby boosting the growth of the segment.

Whereas, the moist heat terminal sterilization segment is expected to witness the highest CAGR of 10.6% during the forecast period. This growth is owing to increasing use of the sterilization technique in all hospitals to disinfect medical equipment, such as surgical scalpels.Over the past decade, these techniques have been increasingly accepted owing to their applications in the dairy and pharmaceutical industry as well as R&D organizations. Advantages of using heat sterilization methods, such as the ability to sterilize liquid substances, nontoxicity, and their inexpensive nature, are boosting market penetration of these techniques. This is expected to help the segment sustain its dominance over the forecast period.

End-use Insights

The pharma segment dominated the market for terminal sterilization services and accounted for the largest revenue share of 67.0% in 2020. Increase in R&D activities results in increased demand for various sterilization processes in the pharmaceutical and biotechnology industry. Thus, rise in need for sterilization of manufacturing equipment and packages have led to demand for terminal sterilization process in pharmaceutical companies. In addition, FDA regulations and guidelines for pharmaceutical preparations are other major factors resulting in rising adoption of advanced and effective sterilization methods, such as sterilization through X-rays and gamma rays, thus, contributing to the growth of the segment.

India terminal sterilization service market share, by end-use, 2020 (%)

Whereas, the hospitals and clinics segment is expected to show lucrative growth over the forecast period owing to the increase in volume of surgical procedures as well as rising cases of hospital-acquired infections in healthcare facilities. Maintaining proper hygiene and sanitation is necessary to sustain a healthy environment in the hospitals and clinics. In addition, the outbreak of COVID-19 requires the adoption of preventive measures for containing the spread of disease; therefore, hospitals and clinics are undertaking preventive measures. These factors are expected to drive adoption of terminal sterilization services in hospitals and clinics, thereby boosting segment growth over the forecast period.

Regional Insights

North America dominated the terminal sterilization services market and accounted for a revenue share of 35.6% in 2020. This can be attributed to the factors such as high prevalence of hospital-acquired infections, advanced healthcare infrastructures, and favorable reimbursement policies. Moreover, strict regulatory policies to deliver safe and quality healthcare services are anticipated to fuel market growth over the forecast period. For instance, the Patient Protection and Affordable Care Act, mandates the usage of terminal sterilization processes in healthcare facilities in this region. In addition, rising number of surgeries and expanding workers in the healthcare sector may boost the demand for such services. Hence, these factors are expected to propel the growth of the market for terminal sterilization services over the forecast period.

In Asia Pacific, the market is expected to witness the highest CAGR of 10.6% from 2021 to 2028 owing to factors increasing incidence of food poisoning, cholera, typhoid fever, and healthcare-associated infections including COVID-19. The growing demand for reusable medical devices is also anticipated to propel the growth of the market for terminal sterilization services. Moreover, major market players are also making efforts to enter untapped markets such as India, China, and Korea, thereby expanding the market scope. In addition, rapidly increasing number of hospitals and laboratories in this region and the booming medical tourism industry is propelling market growth in the region.

Key Companies & Market Share Insights

Product modifications and extensive R&D activities are among the major competitive strategies adopted by market players. For instance, in November 2020, Matachana Group introduced the new S1500 Series. It is a bulk-capacity steam sterilizer with multiple advantages such as easy maintenance, ergonomics, and easy connectivity, which can be used at research centers and laboratories. Thus, such initiatives are expected to boost the company’s market revenue during the forecast period.

Furthermore, the companies are expanding their geographic location to cater the untapped market for terminal sterilization services along with many acquisitions. For instance, in August 2020, Sterigenics acquired Canadian-based Iotron Industrie-a leading outsourcing services provider of E Beam sterilization for medical devices and a wide range of industrial applications in North America. This acquisition expands the company's electron beam footprint and adds new expertise to its business. Similarly, in January 2021, Steris announced to acquire Cantel Medical, through a U.S. subsidiary in a deal valued at USD 4.7 billion in cash. This acquisition would provide broad set of customers with more diversified collection of infection prevention and procedural products and services. Some of the prominent players in the terminal sterilization services market include:

  • Steris Plc

  • Getinge Group

  • Advanced Sterilization Products Services, Inc.

  • 3M

  • Belimed

  • Cantel Medical

  • Matachana Group

  • Sterigenics International LLC

  • Olympus Corp.

  • TSO3

Terminal Sterilization Services Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 9.8 billion

Revenue forecast in 2028

USD 19.5 billion

Growth Rate

CAGR of 10.3% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; U.K.; Germany; France; Italy; Spain; Japan; China; India; Australia; South Korea; Brazil; Mexico; Colombia; Argentina; South Africa; Saudi Arabia; UAE

Key companies profiled

Steris Plc; Getinge Group; Advanced Sterilization Products Services, Inc.; 3M; Belimed; Cantel Medical; Matachana Group; Sterigenics International LLC; Olympus Corp. TSO3

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

 

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global terminal sterilization services market report on the basis of product, end-use, and region:

  • Product Outlook (Revenue, USD million, 2016 - 2028)

    • Ethylene Oxide

    • Irradiation

    • Moist Heat Terminal Sterilization

    • Others

  • End-use Outlook (Revenue, USD million, 2016 - 2028)

    • Hospitals & Clinics

    • Pharma

    • Others

  • Regional Outlook (Revenue, USD million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

      • France

      • Italy

      • Spain

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

    • Latin America

      • Brazil

      • Mexico

      • Argentina

      • Colombia

    • Middle East & Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

Frequently Asked Questions About This Report

gvr icn

GET A FREE SAMPLE

gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself...

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon D&B icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.